American Enterprise Institute

William C. Wood, Nuclear Safety Risks and Regulations, American Enterprise Institute for Public Policy, Washington, DC, 1983. 

Chris Whipple, Redistributing Risk, Regulation Journal on Government and Society, American Enterprise Institute, Washington, DC, May/june 1985, pp. 37-44. 

Mikesell, R. F. (1977). The Rite of Discount for Evaluating Public Projects. AEI Studies 184. Washington, DC American Enterprise Institute for Public Policy Research. Peirce, W. S. (1996). Economics of the Energy Industries. Westport, CT Praeger. 

Grabowski, H.G. and Vernon, J.M. (1983). The Regulation of Pharmaceuticals. American Enterprise Institute, Washington, D.C. 

Gosse, M.E., Manocchia, M., and Nelson, T.F., Overview of US Pharmaceutical Development, 1980-1994, Tufts University Center for the Study of Drug Development, May, 1996. Grabowski, H.G. and Vernon, J., The search for new vaccines the errors of the vaccines for children program, American Enterprise Institute, Washington, 1994. 

Warden W, ed. Controlling the Use of Therapeutic Drugs An International Comparison, Washington, DC American Enterprise Institute for Pubhc Pohcy Research, 1978. 

Studies in the Regulation of Economic Activity series, the American Enterprise Institute s Studies in Government Regulation series, and the Cato Institute s Regulation journal. Finally, I refer the reader to the writings from the "Chicago School" authors Becker, Peltzman, Posner, and Stigler as weU as almost any issue of The Journal of Law... 

Peltzman, Sam. 1974. Regulation of Pharmaceutical Innovation The 1962 Amendments. Washington American Enterprise Institute. 

Grabowski, H. G., "Drug Regulation and Innovation", American Enterprise Institute for Public Policy Research. Library of Congress Catalog Card No. 76-25709 (1976). 

W. Wardell and L. Lasagna, Regulation and Drug Development", American Enterprise Institute, 1975. 

H. Grabowski, "Drug Regulation and Innovation", American Enterprise Institute, 1976. 

Grabowski, H.G., "Regulation and the International Diffusion of Pharmaceuticals," paper presented at the symposium on "The International Supply of Medicines," American Enterprise Institute for Public Policy Research, Washington, D.C., 1978. Grabowski, H.G., Vernon, J.M., and Thomas, L.G., J. Law Econ., (1978) 23, 133. 

Peltzman, S., "Regulation of Pharmaceutical Innovation The 1962 Amendments," American Enterprise Institute for Public Policy Research, Washington, D.C., 1974. 

Helms, R.B. (1999). The tax treatment of health insurance early history and evidence, 1940-1970. In Empowering Health Care Consumers through Tax Reform, G.-M. Arnett, Ed. Washington, D.C. American Enterprise Institute, pp. 73-100. 

Cocks, D.L. Product innovation and the dynamic elements of competition in the ethical pharmaceutical industry. In Drug Development and Marketing, Helms, R.B., Ed. American Enterprise Institute Washington, D.C., 1975 225-254. 

Murray C 1998 Income, inequality, and IQ. American Enterprise Institute, Washington, DC Neisser U, Boodoo G, Bouchard TJ Jr et al 1996 Intelligence knowns and unknowns. Am Psychol 51 77-101... 

Crout, J. R. R D Process Decision Making. In Drugs and Health Economic Issues and Policy Objectives, ed. R. Helms. Washington, D.C. American Enterprise Institute, 1981. 

Pharmaceutical Industry, Journal of Political Economy 80(1) 70-85,1972. D. Schwartzman, The Expected Return From Pharmaceutical Research (Washington, DC American Enterprise Institute, 1975). R. Hansen, The Pharmaceutical Development Process Estimates of Development Costs and Times and the Effect of Proposed Regulator Changes, ... 

Rosanne Altshuler" Assistant Professor of Economies Rutgers University New Brunswick, NJ Robert B. Helms, Workshop Chair Resident Scholar American Enterprise Institute Washington, DC Alison Masson Keith" Assistant Director for Economic Analysis Pfizer, Inc. New York, NY 10017... 

Clarkson, K.W., Intangible Capital and Rates of Return (Washington, DC American Enterprise Institute, 1977). 

Resident Scholar American Enterprise Institute Washington, DC... 

Smalley, H. E. (1982), Hospital Management Engineering, Prentice Hrill, Englewood Qiffs, NJ. Steinwelds, B., and Sloan, F. (1981) Regulatory Approvals to Hospiteil Cost Contmnment A Synthesis of the Empirical Evidence, in A New Approach to the Economics of Health Care, M. Olsin, Ed., American Enterprise Institute, Washington, DC., pp. 274-308. 

It should also not pass without notice that Smith s fable was paid for and disseminated by the trolls themselves at the American Enterprise Institute, a Washington think tank financed by conservative business interests. Smith is in excellent company in this respect many of the country s most distinguished economists have been in the employ of AEI at one time or another. 

Smith, Robert S. 1976. The Occupational Safety and Health Act Its Goals and Achievements. Washington The American Enterprise Institute. 

Compensation, Washington, DC American Enterprise Institute for Public Policy Research. 

The financial externalities for mortality risks are estimated in Martin J. Bailey Reducing the Risks to Life Measurement of the Benefits (Washington, D.C. American Enterprise Institute, 1980). My calculation is based on figures found in U. S. Department of Transportation. National Highway Traffic Safety Administration. The Economic Cost to Society of Motor Vehicle Accidents. DOT HS 806 342, January 1983, pp. 1-4 and 1-5. 

For a technical presentation of the approach and analysis see Sam Peltzman. The Effects of Automobile Safety Regulation. (1975a). For a less technical, interpretive presentation see Sam Peltzman. Regulation of Automobile Safety (Washington, D.C. American Enterprise Institute, 1975b). 

---